The Kamra small-aperture intracorneal inlay improved near vision both monocularly and binocularly in patients with emmetropic presbyopia, according to a study.
The prospective clinical trial included 507 patients with emmetropic presbyopia who underwent intracorneal implantation of the inlay in their nondominant eye. Visual acuity, safety and effectiveness of the Kamra inlay (CorneaGen) were evaluated, with final follow-up at 36 months.
“Kamra inlay has been shown to maintain its safety and effectiveness 3 years after implantation. Patients benefit from improved near vision without
Uncategorized